Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Looking at the year ahead in 2024, a strategy of releasing lab-modified mosquitoes to prevent the spread of dengue fever is poised to scale up after a series of successes. The Aedes aegypti mosquitoes, developed and tested by the non-profit World Mosquito Program […]
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Eli Lilly, maker of the anti-obesity drug Zepbound, announced last week the launch of LillyDirect, a direct-to-patient portal, allowing some patients to obtain its drug for as little as $25 a month. The move is seen as a major shift in the way
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Consulting firm McKinsey & Co has agreed to pay $78 million to resolve claims by U.S. health insurers and benefit plans that it fuelled an epidemic of opioid addiction through its work for drug companies including OxyContin maker Purdue Pharma. https://www.reuters.com/legal/mckinsey-pay-78-million-us-opioid-settlement-with-health-plans-2023-12-30/
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi For the first time since it declared an end to the global Public Health Emergency for COVID-19 on 05 May, the World Health Organization (WHO) has called the COVID-19 variant JN.1 a standalone “variant of interest.” WHO has gone further to
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Gavi, the Vaccine Alliance, has committed up to $1 billion to bolster Africa’s ability to sustainably produce its own doses of lifesaving vaccines. Manufacturers based in Africa produce only 1% of the vaccine doses used on the continent. https://www.science.org/content/article/news-glance-ai-rules-europe-vaccines-africa-and-union-nih-early-career-researchers? Last week,
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi US President Joe Biden has stepped into a long-running debate about whether the National Institutes of Health (NIH) has legal authority to override an exclusive patent license granted to drug developers if they charge too much for treatments that relied on
Biden weighs in on drug costs in US; The latest health stories from around the world Read More »
Article by Lalita Panicker, Consulting Editor, Views, Hindustan Times, and Editor, Insight, Hindustan Times, New Delhi Last month, the World Health Organization (WHO) revealed that the Democratic Republic of the Congo (DRC) was experiencing its largest, most deadly outbreak of mpox ever, with more than 12,000 suspected cases so far this year and nearly 600
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi In a world first, U.K. regulators have approved a therapy that uses CRISPR, the Nobel Prize–winning gene-editing tool invented in 2012. The treatment has been shown to help people with beta thalassemia and sickle cell disease, both inherited blood disorders that
UK approves CRISPR gene therapy for SCD; The latest health stories from around the world Read More »
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi A technique for precisely rewriting the genetic code directly in the body has slashed “bad” cholesterol levels—possibly for life—in three people prone to dangerously high levels of the artery-clogging fat. The feat relied on a blood infusion of a so-called base
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi At last, the world’s largest biomedical research agency has a permanent leader. The U.S. Senate recently voted 62-36 to confirm oncologist to direct the U.S. National Institutes of Health (NIH). https://www.science.org/content/article/u-s-senate-confirms-monica-bertagnolli-nih-director? The confirmation of Bertagnolli, who is expected to be sworn
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues Africa | All rights reserved.
